PJA1 Antikörper (FITC)
Kurzübersicht für PJA1 Antikörper (FITC) (ABIN1401560)
Target
Alle PJA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human RNF70
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P) 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- PJA1 (Praja Ring Finger 1, E3 Ubiquitin Protein Ligase (PJA1))
-
Andere Bezeichnung
- RNF70
-
Hintergrund
-
Synonyms: E3 ubiquitin-protein ligase Praja 1, E3 ubiquitin-protein ligase Praja-1, PJA1, PJA1_HUMAN, PRAJA 1, Praja ring finger 1, Praja1, Ring Finger Protein 70.
Background: Has E2-dependent E3 ubiquitin-protein ligase activity. Ubiquitinates MAGED1 antigen leading to its subsequent degradation by proteasome (By similarity). May be involved in protein sorting.
-
Gen-ID
- 64219
Target
-